Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 1161

1.

[Utility of quetiapine in tardive dyskinesia].

Navarro Pacheco BV, Montejo González AL, Martín Carrasco M.

Actas Esp Psiquiatr. 2003 Nov-Dec;31(6):347-52. Review. Spanish.

PMID:
14639511
2.

A single-blind, randomized trial comparing quetiapine and haloperidol in the treatment of tardive dyskinesia.

Emsley R, Turner HJ, Schronen J, Botha K, Smit R, Oosthuizen PP.

J Clin Psychiatry. 2004 May;65(5):696-701.

PMID:
15163258
3.

Adjunctive quetiapine decreases symptoms of tardive dyskinesia in a patient taking risperidone.

Nelson MW, Reynolds RR, Kelly DL, Conley RR.

Clin Neuropharmacol. 2003 Nov-Dec;26(6):297-8.

PMID:
14646608
4.

Using antipsychotic agents in older patients.

Alexopoulos GS, Streim J, Carpenter D, Docherty JP; Expert Consensus Panel for Using Antipsychotic Drugs in Older Patients.

J Clin Psychiatry. 2004;65 Suppl 2:5-99; discussion 100-102; quiz 103-4. Review.

5.

Quetiapine-induced improvement of tardive dyskinesia in three patients with schizophrenia.

Alptekin K, Kivircik BB.

Int Clin Psychopharmacol. 2002 Sep;17(5):263-4.

PMID:
12177588
6.

Clinical predictors of acute response with quetiapine in psychotic mood disorders.

Zarate CA Jr, Rothschild A, Fletcher KE, Madrid A, Zapatel J.

J Clin Psychiatry. 2000 Mar;61(3):185-9.

PMID:
10817103
7.

[Atypical antipsychotics and sexual dysfunction: five case-reports associated with risperidone].

Haefliger T, Bonsack C.

Encephale. 2006 Jan-Feb;32(1 Pt 1):97-105. French.

PMID:
16633296
8.

Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study.

Bai YM, Yu SC, Lin CC.

J Clin Psychiatry. 2003 Nov;64(11):1342-8.

PMID:
14658949
9.

Tardive dyskinesia in a patient treated with quetiapine.

Rizos E, Douzenis A, Gournellis R, Christodoulou C, Lykouras LP.

World J Biol Psychiatry. 2009;10(1):54-7.

PMID:
19673087
10.
11.

Incidence of tardive dyskinesia in first-episode psychosis patients treated with low-dose haloperidol.

Oosthuizen PP, Emsley RA, Maritz JS, Turner JA, Keyter N.

J Clin Psychiatry. 2003 Sep;64(9):1075-80.

PMID:
14628983
12.

The safety and pharmacokinetics of quetiapine when coadministered with haloperidol, risperidone, or thioridazine.

Potkin SG, Thyrum PT, Alva G, Bera R, Yeh C, Arvanitis LA.

J Clin Psychopharmacol. 2002 Apr;22(2):121-30.

PMID:
11910256
13.

Quetiapine in the treatment of focal tardive dystonia induced by other atypical antipsychotics: a report of 2 cases.

Gourzis P, Polychronopoulos P, Papapetropoulos S, Assimakopoulos K, Argyriou AA, Beratis S.

Clin Neuropharmacol. 2005 Jul-Aug;28(4):195-6.

PMID:
16062102
14.

Low dose quetiapine for drug induced dyskinesias in Parkinson's disease: a double blind cross over study.

Katzenschlager R, Manson AJ, Evans A, Watt H, Lees AJ.

J Neurol Neurosurg Psychiatry. 2004 Feb;75(2):295-7.

15.

[Quetiapine treatment of risperidone-related tardive dyskinesia. A case report].

Alcantara Lapaz AG, García Fernández L, Martínez MJ.

Actas Esp Psiquiatr. 2003 Sep-Oct;31(5):306. Spanish. No abstract available.

PMID:
14557956
16.

Treatment of generalized tardive dystonia with clozapine.

Aukst-Margetić B, Margetić B.

Psychiatr Danub. 2008 Sep;20(3):329-31.

PMID:
18827758
17.

Neuroleptic-related dyskinesias in children and adolescents.

Connor DF, Fletcher KE, Wood JS.

J Clin Psychiatry. 2001 Dec;62(12):967-74.

PMID:
11780878
18.

Risperidone implicated in the onset of tardive dyskinesia in a young woman.

Kumar S, Malone DM.

Postgrad Med J. 2000 May;76(895):316-7.

19.
20.

Treatment of tardive dyskinesia with levetiracetam in a transplant patient.

Zivković SA, Costa G, Bond G, Abu-Elmagd KM.

Acta Neurol Scand. 2008 May;117(5):351-3. Epub 2007 Nov 8.

PMID:
17995990

Supplemental Content

Support Center